文献速递心脏核医学肿瘤 PET/CT

生长抑素受体靶向显像检测心肌炎症的可行性初步研究

Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
PubMed 文献 · J Nucl Cardiol · 2019-06-13

结果显示Dotatate在心肌炎症检测上与FDG总体一致性为54%,心脏FDG最大标准化摄取值是Dotatate的5.0倍,提示生长抑素受体靶向显像对心肌炎症的敏感性可能低于FDG,但检测心外炎症二者相当。

要点

  • 心脏结节病疑似患者中,Dotatate PET心肌异常摄取检出率低于FDG PET。
  • 心脏FDG最大标准化摄取值是Dotatate的5.0倍,胸淋巴结仅2.25倍。
  • 离体结节病心脏肉芽肿内可见弱sstr-2免疫染色,背景心肌无显著染色。

核心结论

  • 与FDG显像相比,生长抑素受体靶向显像检测心肌炎症的敏感性可能较低,但检测心外炎症二者相当。

研究设计与样本

  • 离体分析3例 explanted 结节病心脏标本的生长抑素受体2型免疫组化表达。

主要发现

  • 所有FDG扫描均显示心脏摄取(局灶/多灶6例,弥漫局灶/不均匀7例),46%(n=6)有心脏外摄取(纵隔/肺门)。
  • Dotatate扫描显示明确异常心脏摄取(局灶/多灶)4例,可能异常(不均匀/斑片状)3例,阴性6例;6例纵隔/肺门Dotatate摄取增高。
  • FDG与Dotatate心脏摄取总体一致性为54%,胸部淋巴结活性一致性为100%。
  • 心脏FDG最大标准化摄取值是Dotatate的5.0倍[3.8-7.1],胸部淋巴结仅2.25倍[1.7-3.0;P=.019]。
  • 离体3例结节病心脏标本中,sstr-2免疫染色在成形良好的肉芽肿内弱阳性,背景心肌或正常心肌无显著染色。

临床怎么用

  • 在疑似心脏结节病评估中,Dotatate PET不宜替代FDG PET检测心肌炎症,但可用于评估心外(纵隔/肺门)炎症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gallium-68 Dotatate binds preferentially to somatostatin receptor (sstr) subtype-2 (sstr-2) on inflammatory cells. We aimed at investigating the potential clinical use of sstr-targeted imaging for the detection of myocardial inflammation. METHODS: Thirteen patients, with suspected cardiac sarcoidosis (CS) based on clinical history and myocardial uptake on recent fluorine-18 fluorodeoxyglucose (FDG) PET, were enrolled to undergo Dotatate PET after FDG-PET (median time 37 days [IQR 25-55]). Additionally, we investigated ex-vivo the immunohistochemistry expression of sstr-2 in 3 explanted sarcoid hearts. RESULTS: All FDG scans showed cardiac uptake (focal/multifocal = 6, focal on diffuse/heterogeneous = 7), and 46% (n = 6) extra-cardiac uptake (mediastinal/hilar). In comparison, Dotatate scans showed definite abnormal cardiac uptake (focal/multifocal) in 4 patients, probably abnormal (heterogenous/patchy) in 3, and negative uptake in 6 cases. Similarly, 6 patients had increased mediastinal/hilar Dotatate uptake. Overall concordance of FDG and Dotatate uptake was 54% in the heart and 100% for thoracic nodal activity. Quantitatively, FDG maximum standardized uptake value was 5.0 times [3.8-7.1] higher in the heart, but only 2.25 times [1.7-3.0; P = .019] higher in thoracic nodes relative to Dotatate. Ex-vivo, sstr-2 immunostaining was weakly seen within well-formed granulomas in all 3 examined sarcoid heart specimens with no significant staining of background myocardium or normal myocardium. CONCLUSION: Our preliminary data suggest that, compared to FDG imaging, somatostatin receptor-targeted imaging may be less sensitive for the detection of myocardial inflammation, but comparable for detecting extra-cardiac inflammation.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Bravo PE, Bajaj N, Padera RF, et al. Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study. J Nucl Cardiol. 2019. PMID: 31197742. doi:10.1007/s12350-019-01782-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。